Navigation Links
Regado Biosciences, Inc. Announces Exercise of Over-Allotment Option
Date:9/6/2013

BASKING RIDGE, N.J., Sept. 6, 2013 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO), today announced the exercise of the over-allotment option granted to the underwriters to purchase 921,500 additional shares of common stock, at a public offering price of $4.00 per share, in connection with its previously announced initial public offering of 10,750,000 shares of common stock, bringing the total gross proceeds from the offering to $46,686,000, before deducting the underwriting discounts and commissions and other offering expenses payable by Regado Biosciences.  All of the common stock was offered by Regado Biosciences.  The company's common stock is listed on The NASDAQ Capital Market under the trading symbol "RGDO."

Cowen and Company, LLC and BMO Capital Markets Corp. acted as joint book-running managers for the offering.  Canaccord Genuity Inc., Needham & Company, LLC, and Wedbush PacGrow Life Sciences acted as co-managers. 

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on August 21, 2013.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus.  Copies of the final prospectus related to the offering may be obtained from Cowen and Company, LLC, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY,11717, Attn: Prospectus Department, Phone (631) 274-2806 / Fax (631) 254-7140; or from BMO Capital Markets Corp., Attention: Equity Syndicate Department, 3
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
2. Regado Biosciences, Inc. to Present at Needham & Companys 11th Annual Healthcare Conference in New York, NY
3. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
4. Pressure BioSciences, Inc. to Discuss Second Quarter 2013 Financial Results and Provide a Business Update
5. Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal
6. Pressure BioSciences, Inc. to Discuss First Quarter 2013 Financial Results and Provide Business Update
7. Pressure BioSciences, Inc. Appoints Conrad F. Mir as Chief Financial Officer
8. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
9. Pressure BioSciences, Inc. Reaches Agreement with Investors on Initial $600,000 Tranche of $1.2 Million Above-Market Private Placement; Proceeds to Support Continued Commercialization of PCT Product Platform
10. Shire to Acquire FerroKin BioSciences, Inc., and its Phase 2 Iron Chelator Treatment
11. Clinverse, Inc. Announces Strategic Partnership With OmniComm Systems, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Applying a well-known optical phenomenon called thin-film interference, ... demonstrated the ability to "paint" ultra-thin coatings onto ... for making future, flexible electronic devices, creating advanced ... rocket ships and spacecraft with extremely lightweight decorative ... water, it becomes iridescent, revealing a myriad of ...
(Date:9/30/2014)... AMHERST, Mass. Using a bio-mimicking analog of ... of grass, an international research team led by ... has taken a major step in developing long-sought ... to electricity for use in electronic devices. ... UMass Amherst and others at Stanford University and ...
(Date:9/30/2014)... , Sept. 30, 2014 Report ... segments with highest potential revenues Do you want ... report gives you revenue predictions for those biological ... those therapies you find financial data, R&D trends, ... you get sales forecasts to 2024 at overall ...
(Date:9/30/2014)... YORK , Sept. 30, 2014 ... to kill nematodes. Nematodes are microscopic parasitic roundworms, ... water, and inside other plants and animals. Nematicides ... volatility or other properties promoting migration through the ... more than 1,000 plant-parasitic nematodes. With more than ...
Breaking Biology Technology:Taking thin films to the extreme 2Blades of grass inspire advance in organic solar cells 2Blades of grass inspire advance in organic solar cells 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 2Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 3Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 4Biosimilars and Follow-On Biologics: World Industry and Market Prospects 2014-2024 5Nematicides Market by Types (Fumigants, Organophosphates, Carbamate and Bio-Nematicides), Applications (Agrochemicals, Industrial, and Others), and Geography (North America, Europe, Asia-Pacific & ROW) - Global Trends & Forecasts to 2019 2
... (Nasdaq: SPEX ), an innovator in biotechnology ... providers of technical and regulatory consulting services to food, ... President, Dr. Robert Lodder, will be presenting at the ... held in New York next week. Dr. ...
... announced today they have engaged in a pilot with ... Chemotherapy for Cancer patients. Medical and GYN Oncologists and ... (Nashville, TN) using the MiCK assay for apoptosis in ... the best chemotherapy pathway in treating cancer patients. The ...
... BELL, Pa., Feb. 8, 2011 Inovio Pharmaceuticals, Inc. (NYSE ... of therapeutic and preventive vaccines against cancers and infectious diseases, ... will present a corporate overview on Inovio at the 13th ... York February 14-15, 2011. A live and archived ...
Cached Biology Technology:Spherix to Present at the 13th Annual BIO CEO & Investor Conference 2Spherix to Present at the 13th Annual BIO CEO & Investor Conference 3DiaTech Oncology and Walter Reed Army Medical Center Establish Pilot to Determine Best Chemotherapy for Cancer Patients 2Inovio Pharmaceuticals to Present at 13th Annual BIO CEO & Investor Conference 2Inovio Pharmaceuticals to Present at 13th Annual BIO CEO & Investor Conference 3
(Date:10/1/2014)... of non-genetic inheritance, showing for the first time that ... in flies at least., This confronting idea, known as ... discredited in the early 20th Century with the advent ... Dr Angela Crean, Professor Russell Bonduriansky and Dr Anna ... their offspring., They found that the size of the ...
(Date:10/1/2014)... University researchers hope to take a healthy salad up ... form of breast cancer in leafy greens. , "In ... vaccine either by eating the salad or making a ... professor of biomedical engineering at Case Western Reserve School ... Susan G. Komen breast cancer organization is funding the ...
(Date:10/1/2014)... 1, 2014 Neuartiger ... Biowissenschaften   Die Biowissenschaften erlebten in ... zahlreicher Detektionstechnologien. Einige davon sind Senkrechtstarter und ... Photonen-Upconversion ist eine neuartige Detektionstechnologie, die von ... aufgenommen wurde. Jetzt ist diese Technologie endlich ...
Breaking Biology News(10 mins):Semen secrets: How a previous sexual partner can influence another male's offspring 2Scientists wield plant viruses against deadly human disease 2Scientists wield plant viruses against deadly human disease 3Innovative Verwendungslösung für die Photonen-Upconversion 2Innovative Verwendungslösung für die Photonen-Upconversion 3
... Data publishers should have the option of submitting ... discussion paper commissioned by the Global Biodiversity Information Facility ... of recommendations made by Mark Costello and co-authors in ... advancing biodiversity data publication , freely available for ...
... 24, 2012 Millions of people with "wet" macular degeneration ... But now scientists at The Scripps Research Institute (TSRI) have ... more harm than good. In the new study, ... VEGF, which has been implicated in stimulating abnormal blood vessel ...
... high resolution draft of the barley genome. The research, published ... new and better barley varieties that are vital for the ... research was led by Professor Robbie Waugh of Scotland,s James ... Centre, Norwich. Barley is the second most important crop ...
Cached Biology News:Peer review option proposed for biodiversity data 2Study suggests caution and further studies on drugs used to treat macular degeneration 2Study suggests caution and further studies on drugs used to treat macular degeneration 3Barley genome could hold key to better beer 2
Request Info...
... KLH-conjugated, synthetic peptide corresponding ... of human BRAF-HDAC complex protein/Lysine-specific ... Quality Assurance Routinely evaluated ... 2 years at -20°C ...
...
...
Biology Products: